Ionizing radiation biomarkers in epidemiological studies - An update
Recent epidemiology studies highlighted the detrimental health effects of exposure to low dose and low dose rate ionizing radiation (IR): nuclear industry workers studies have shown increased leukaemia and solid tumour risks following cumulative doses of <100mSv and dose rates of <10mG...
| Autores: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión aceptada para publicación |
| Fecha de publicación: | 2017 |
| País: | España |
| Institución: | Universitat Pompeu Fabra |
| Repositorio: | Repositorio Digital de la UPF |
| OAI Identifier: | oai:repositori.upf.edu:10230/34940 |
| Acceso en línea: | http://hdl.handle.net/10230/34940 http://dx.doi.org/10.1016/j.mrrev.2017.01.001 |
| Access Level: | acceso abierto |
| Palabra clave: | Marcadors bioquímics Radiació ionitzant |
| id |
ES_bbdc04cb6029ab3dcb02e0280d742ed9 |
|---|---|
| oai_identifier_str |
oai:repositori.upf.edu:10230/34940 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Ionizing radiation biomarkers in epidemiological studies - An updateHall, JanetJeggo, Penny A.West, CatharineGomolka, MariaQuintens, RoelBadie, ChristopheLaurent, OlivierAerts, AnnAnastasov, NatašaAzimzadeh, OmidAzizova, TamaraBaatout, SarahBaselet, BjornBenotmane, Mohammed A.Blanchardon, EricGuéguen, YannHaghdoost, SiamakHarms-Ringhdahl, MatsHess, JuliaKreuzer, MichaelaLaurier, DominiqueMacaeva, EllinaManning, GrainPernot, EileenRavanat, Jean-LucSabatier, LaureTack, KarineTapio, SoileZitzelsberger, HorstCardis, ElisabethMarcadors bioquímicsRadiació ionitzantRecent epidemiology studies highlighted the detrimental health effects of exposure to low dose and low dose rate ionizing radiation (IR): nuclear industry workers studies have shown increased leukaemia and solid tumour risks following cumulative doses of <100mSv and dose rates of <10mGy per year; paediatric patients studies have reported increased leukaemia and brain tumours risks after doses of 30-60mGy from computed tomography scans. Questions arise, however, about the impact of even lower doses and dose rates where classical epidemiological studies have limited power but where subsets within the large cohorts are expected to have an increased risk. Further progress requires integration of biomarkers or bioassays of individual exposure, effects and susceptibility to IR. The European DoReMi (Low Dose Research towards Multidisciplinary Integration) consortium previously reviewed biomarkers for potential use in IR epidemiological studies. Given the increased mechanistic understanding of responses to low dose radiation the current review provides an update covering technical advances and recent studies. A key issue identified is deciding which biomarkers to progress. A roadmap is provided for biomarker development from discovery to implementation and used to summarise the current status of proposed biomarkers for epidemiological studies. Most potential biomarkers remain at the discovery stage and for some there is sufficient evidence that further development is not warranted. One biomarker identified in the final stages of development and as a priority for further research is radiation specific mRNA transcript profiles.Research in many of the authors’ laboratories has in-part been supported by the EU FP7 (Grant Number 249689) for the Network of Excellence DoReMi (Low Dose Research towards Multidisciplinary Integration)Elsevier201820182017info:eu-repo/semantics/articleinfo:eu-repo/semantics/acceptedVersionapplication/pdfapplication/pdfhttp://hdl.handle.net/10230/34940http://dx.doi.org/10.1016/j.mrrev.2017.01.001reponame:Repositorio Digital de la UPFinstname:Universitat Pompeu FabraInglésMutation Research. 2017 Jan - Mar;771:59-84info:eu-repo/grantAgreement/EC/FP7/249689© Elsevier http://dx.doi.org/10.1016/j.mrrev.2017.01.001info:eu-repo/semantics/openAccessoai:repositori.upf.edu:10230/349402026-06-12T07:21:37Z |
| dc.title.none.fl_str_mv |
Ionizing radiation biomarkers in epidemiological studies - An update |
| title |
Ionizing radiation biomarkers in epidemiological studies - An update |
| spellingShingle |
Ionizing radiation biomarkers in epidemiological studies - An update Hall, Janet Marcadors bioquímics Radiació ionitzant |
| title_short |
Ionizing radiation biomarkers in epidemiological studies - An update |
| title_full |
Ionizing radiation biomarkers in epidemiological studies - An update |
| title_fullStr |
Ionizing radiation biomarkers in epidemiological studies - An update |
| title_full_unstemmed |
Ionizing radiation biomarkers in epidemiological studies - An update |
| title_sort |
Ionizing radiation biomarkers in epidemiological studies - An update |
| dc.creator.none.fl_str_mv |
Hall, Janet Jeggo, Penny A. West, Catharine Gomolka, Maria Quintens, Roel Badie, Christophe Laurent, Olivier Aerts, Ann Anastasov, Nataša Azimzadeh, Omid Azizova, Tamara Baatout, Sarah Baselet, Bjorn Benotmane, Mohammed A. Blanchardon, Eric Guéguen, Yann Haghdoost, Siamak Harms-Ringhdahl, Mats Hess, Julia Kreuzer, Michaela Laurier, Dominique Macaeva, Ellina Manning, Grain Pernot, Eileen Ravanat, Jean-Luc Sabatier, Laure Tack, Karine Tapio, Soile Zitzelsberger, Horst Cardis, Elisabeth |
| author |
Hall, Janet |
| author_facet |
Hall, Janet Jeggo, Penny A. West, Catharine Gomolka, Maria Quintens, Roel Badie, Christophe Laurent, Olivier Aerts, Ann Anastasov, Nataša Azimzadeh, Omid Azizova, Tamara Baatout, Sarah Baselet, Bjorn Benotmane, Mohammed A. Blanchardon, Eric Guéguen, Yann Haghdoost, Siamak Harms-Ringhdahl, Mats Hess, Julia Kreuzer, Michaela Laurier, Dominique Macaeva, Ellina Manning, Grain Pernot, Eileen Ravanat, Jean-Luc Sabatier, Laure Tack, Karine Tapio, Soile Zitzelsberger, Horst Cardis, Elisabeth |
| author_role |
author |
| author2 |
Jeggo, Penny A. West, Catharine Gomolka, Maria Quintens, Roel Badie, Christophe Laurent, Olivier Aerts, Ann Anastasov, Nataša Azimzadeh, Omid Azizova, Tamara Baatout, Sarah Baselet, Bjorn Benotmane, Mohammed A. Blanchardon, Eric Guéguen, Yann Haghdoost, Siamak Harms-Ringhdahl, Mats Hess, Julia Kreuzer, Michaela Laurier, Dominique Macaeva, Ellina Manning, Grain Pernot, Eileen Ravanat, Jean-Luc Sabatier, Laure Tack, Karine Tapio, Soile Zitzelsberger, Horst Cardis, Elisabeth |
| author2_role |
author author author author author author author author author author author author author author author author author author author author author author author author author author author author author |
| dc.subject.none.fl_str_mv |
Marcadors bioquímics Radiació ionitzant |
| topic |
Marcadors bioquímics Radiació ionitzant |
| description |
Recent epidemiology studies highlighted the detrimental health effects of exposure to low dose and low dose rate ionizing radiation (IR): nuclear industry workers studies have shown increased leukaemia and solid tumour risks following cumulative doses of <100mSv and dose rates of <10mGy per year; paediatric patients studies have reported increased leukaemia and brain tumours risks after doses of 30-60mGy from computed tomography scans. Questions arise, however, about the impact of even lower doses and dose rates where classical epidemiological studies have limited power but where subsets within the large cohorts are expected to have an increased risk. Further progress requires integration of biomarkers or bioassays of individual exposure, effects and susceptibility to IR. The European DoReMi (Low Dose Research towards Multidisciplinary Integration) consortium previously reviewed biomarkers for potential use in IR epidemiological studies. Given the increased mechanistic understanding of responses to low dose radiation the current review provides an update covering technical advances and recent studies. A key issue identified is deciding which biomarkers to progress. A roadmap is provided for biomarker development from discovery to implementation and used to summarise the current status of proposed biomarkers for epidemiological studies. Most potential biomarkers remain at the discovery stage and for some there is sufficient evidence that further development is not warranted. One biomarker identified in the final stages of development and as a priority for further research is radiation specific mRNA transcript profiles. |
| publishDate |
2017 |
| dc.date.none.fl_str_mv |
2017 2018 2018 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/acceptedVersion |
| format |
article |
| status_str |
acceptedVersion |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/10230/34940 http://dx.doi.org/10.1016/j.mrrev.2017.01.001 |
| url |
http://hdl.handle.net/10230/34940 http://dx.doi.org/10.1016/j.mrrev.2017.01.001 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.relation.none.fl_str_mv |
Mutation Research. 2017 Jan - Mar;771:59-84 info:eu-repo/grantAgreement/EC/FP7/249689 |
| dc.rights.none.fl_str_mv |
© Elsevier http://dx.doi.org/10.1016/j.mrrev.2017.01.001 info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
© Elsevier http://dx.doi.org/10.1016/j.mrrev.2017.01.001 |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf application/pdf |
| dc.publisher.none.fl_str_mv |
Elsevier |
| publisher.none.fl_str_mv |
Elsevier |
| dc.source.none.fl_str_mv |
reponame:Repositorio Digital de la UPF instname:Universitat Pompeu Fabra |
| instname_str |
Universitat Pompeu Fabra |
| reponame_str |
Repositorio Digital de la UPF |
| collection |
Repositorio Digital de la UPF |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869418062663385088 |
| score |
15,811543 |